IVERIC bio, Inc. Common Stock
ISEE
ISEE was delisted on the 10th of July, 2023.
144 hedge funds and large institutions have $1.29B invested in IVERIC bio, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 59 increasing their positions, 45 reducing their positions, and 18 closing their positions.
33% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 18
31% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 45
4% more funds holding
Funds holding: 139 → 144 (+5)
18% less capital invested
Capital invested by funds: $1.58B → $1.29B (-$292M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
32% less call options, than puts
Call options by funds: $4.47M | Put options by funds: $6.56M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$19.4M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$18.2M |
| 3 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$14.4M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$14.2M |
| 5 |
O
OrbiMed
New York
|
+$13.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$17.2M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$16.8M |
| 3 |
SHI
SV Health Investors
Boston,
Massachusetts
|
-$15.5M |
| 4 |
AP
AHL Partners
London,
United Kingdom
|
-$5.28M |
| 5 |
Renaissance Technologies
New York
|
-$5.08M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
151
Arrowstreet Capital
Boston,
Massachusetts
| – | -$979K | -18,800 | Closed |
|
|
HI
152
HBK Investments
Dallas,
Texas
| – | -$729K | -13,999 | Closed |
|
|
HCA
153
Hillview Capital Advisors
Wayne,
Pennsylvania
| – | -$642K | -12,330 | Closed |
|
|
SCM
154
Stevens Capital Management
Radnor,
Pennsylvania
| – | -$404K | -7,757 | Closed |
|
|
PPA
155
Parametric Portfolio Associates
Seattle,
Washington
| – | -$325K | -6,246 | Closed |
|
|
SCA
156
Secor Capital Advisors
New York
| – | -$249K | -4,783 | Closed |
|
|
EGM
157
Engineers Gate Manager
New York
| – | -$214K | -4,106 | Closed |
|
158
Principal Financial Group
Des Moines,
Iowa
| – | -$213K | -4,084 | Closed |
|
159
Acadian Asset Management
Boston,
Massachusetts
| – | -$124K | -2,382 | Closed |
|
|
PCM
160
Prelude Capital Management
New York
| – | -$62K | -1,200 | Closed |
|
|
FANJ
161
Financial Architects (New Jersey)
Marlton,
New Jersey
| – | -$42K | -800 | Closed |
|
|
JG
162
Jefferies Group
New York
| – | -$4K | -73 | Closed |
|
ISEE Hedge Fund Activity: Q3 2015 in Review
144 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q3 2015, worth a combined $1.29B — down 18% from $1.58B a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new ISEE positions and 18 closed out — a net gain of 6 holders — while 59 added to existing stakes and 45 trimmed.
The largest buyer was Vanguard Group, adding an estimated $19.4M. The largest seller was Fidelity Investments, cutting an estimated $17.2M.
- 144 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q3 2015, up from 139 in Q2 2015.
- Funds reported $1.29B of IVERIC bio, Inc. Common Stock stock for Q3 2015, down 18% quarter-over-quarter.
- 24 funds opened new IVERIC bio, Inc. Common Stock positions in Q3 2015 and 18 closed out, a net change of +6 holders.
- The largest IVERIC bio, Inc. Common Stock buyer in Q3 2015 was Vanguard Group, an estimated $19.4M added.
- The largest IVERIC bio, Inc. Common Stock seller in Q3 2015 was Fidelity Investments, an estimated $17.2M sold.
Based on aggregated 13F filings for Q3 2015.